Skip to main content
. 2022 Jan 17;12(2):287. doi: 10.3390/nano12020287

Figure 4.

Figure 4

Biocompatibility study of H2L-MOF nanoparticles. (a) Viability of Hela cells incubated for 8 h in the presence of H2L-MOFs with different concentrations. (b) The body weight trends of the mice injected with H2L-MOFs and H2L- MOFs@DOX (20 μmol Zr per kg). (c) Histological images of the lung, liver, spleen, kidney, intestine, and heart of mice after injection with saline solution (control) and H2L-MOFs (treatment, 20 μmol Zr per kg). Scale bars: 100 μm.